Explore the Mechanism of Astragalus mongholicus Bunge against Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental Verification

Table 3

Ten key targets of ABM in treating NAFLD.

No.	Gene symbol	Description	Degree (DC)	Betweenness centrality (BC)
1	AKT1	RAC-alpha serine/threonine-protein kinase	76	0.09007483
2	IL6	Interleukin-6	75	0.06038545
3	TNF	Tumor necrosis factor	72	0.04427747
4	TP53	Cellular tumor antigen p53	66	0.02811782
5	JUN	Transcription factor AP-1	61	0.01848417
6	PTGS2	Prostaglandin G/H synthase 2	59	0.01631192
7	CXCL8	Interleukin-8	59	0.01898645
8	MAPK8	Mitogen-activated protein kinase 8	58	0.01679413
9	MMP9	Matrix metalloproteinase-9	57	0.02436033
10	CASP3	Caspase-3	57	0.01529514